Matches in Nanopublications for { ?s ?p "[We conclude that acute hyperinsulinemia decreases the hepatic secretion rate of VLDL apoB in NIDDM, probably in part due to reduction in the delivery of NEFA and glycerol substrate to the liver.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP698224.RAsscWOtjh2rbaSuUHzmHkXxnrJCSh3nON68yzDOZ12cA130_assertion description "[We conclude that acute hyperinsulinemia decreases the hepatic secretion rate of VLDL apoB in NIDDM, probably in part due to reduction in the delivery of NEFA and glycerol substrate to the liver.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698224.RAsscWOtjh2rbaSuUHzmHkXxnrJCSh3nON68yzDOZ12cA130_provenance.
- NP420657.RA88lQ3Ba8LLgh6ngxDn6pAK7gMEmVdHx2RCnv2p-03LM130_assertion description "[We conclude that acute hyperinsulinemia decreases the hepatic secretion rate of VLDL apoB in NIDDM, probably in part due to reduction in the delivery of NEFA and glycerol substrate to the liver.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420657.RA88lQ3Ba8LLgh6ngxDn6pAK7gMEmVdHx2RCnv2p-03LM130_provenance.
- NP467140.RAXVZZQ_sq3LIFj-iHfhBd7m_NBFh_5yY_6hrw1yzhFJ0130_assertion description "[We conclude that acute hyperinsulinemia decreases the hepatic secretion rate of VLDL apoB in NIDDM, probably in part due to reduction in the delivery of NEFA and glycerol substrate to the liver.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467140.RAXVZZQ_sq3LIFj-iHfhBd7m_NBFh_5yY_6hrw1yzhFJ0130_provenance.
- NP1316751.RAbJiuwTKbGkllmM6lw1AY0Wa7rhqNabuF1V4ToOkApH8130_assertion description "[We conclude that acute hyperinsulinemia decreases the hepatic secretion rate of VLDL apoB in NIDDM, probably in part due to reduction in the delivery of NEFA and glycerol substrate to the liver.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1316751.RAbJiuwTKbGkllmM6lw1AY0Wa7rhqNabuF1V4ToOkApH8130_provenance.
- NP844083.RALg2RvcJlnKYvr5Ss30mSYRPt0aDa-6mfkFo7faxkIl8130_assertion description "[We conclude that acute hyperinsulinemia decreases the hepatic secretion rate of VLDL apoB in NIDDM, probably in part due to reduction in the delivery of NEFA and glycerol substrate to the liver.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844083.RALg2RvcJlnKYvr5Ss30mSYRPt0aDa-6mfkFo7faxkIl8130_provenance.
- NP243902.RAwizExv4JtEjGNyDvzTsdq6VNamGT3S_OQ3N0J0WG-FY130_assertion description "[We conclude that acute hyperinsulinemia decreases the hepatic secretion rate of VLDL apoB in NIDDM, probably in part due to reduction in the delivery of NEFA and glycerol substrate to the liver.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243902.RAwizExv4JtEjGNyDvzTsdq6VNamGT3S_OQ3N0J0WG-FY130_provenance.
- NP600852.RA6Ffoz5ZPvcuvpUhcVhV1AgucjfAPAsndTN0VxrEWopA130_assertion description "[We conclude that acute hyperinsulinemia decreases the hepatic secretion rate of VLDL apoB in NIDDM, probably in part due to reduction in the delivery of NEFA and glycerol substrate to the liver.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600852.RA6Ffoz5ZPvcuvpUhcVhV1AgucjfAPAsndTN0VxrEWopA130_provenance.
- NP1316750.RA1qZZNTfcBeyk_Eo7yOcXfl_3ILqHn_TfLTzCEyDDQ_A130_assertion description "[We conclude that acute hyperinsulinemia decreases the hepatic secretion rate of VLDL apoB in NIDDM, probably in part due to reduction in the delivery of NEFA and glycerol substrate to the liver.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1316750.RA1qZZNTfcBeyk_Eo7yOcXfl_3ILqHn_TfLTzCEyDDQ_A130_provenance.